Gender differences in genetic susceptibility for lung cancer.

In contrast to men, the incidence of lung cancer among women has increased over the past decade. The basis for this increase among female smokers remains unknown. Surgical patients with a diagnosis of lung cancer and control subjects without a history of malignancy completed a smoking questionnaire and donated a blood sample. DNA was extracted from peripheral mononuclear cells and genotyped for polymorphisms in cytochrome P450 1A1 (CYP1A1) (exon 7) and glutathione S-transferase M1 (GSTM1) (null). No gender differences in either age at diagnosis or histological subtype were observed among lung cancer patients. In both patients (n = 180) and controls (n = 163), females smoked significantly less than males. The pack-year history associated with adenocarcinoma was smaller than that for squamous cell carcinoma. No significant association was observed between the GSTM1 null genotype and cancer risk. However, women had a larger cancer risk than men (odds ratio 4.98 vs. 1.37) if they possessed the mutant CYP1A1 genotype. Female cancer patients were significantly more likely than female controls to have both the CYP1A1 mutation and GSTM1 null genotype. The combined variant genotypes conferred an odds ratio of 6.54 for lung cancer in women versus 2.36 for men, independent of age or smoking history. These data suggest that polymorphisms in CYP1A1 and GSTM1 contribute to the increased risk of females for lung cancer.

[1]  Women and lung cancer: waiting to exhale. , 1997, Chest.

[2]  D. Phillips,et al.  Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. , 1999, Cancer research.

[3]  R. Houlston.  Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  K. Nakachi,et al.  The CYP1A1 gene and cancer susceptibility. , 1993, Critical reviews in oncology/hematology.

[5]  R. Clayton,et al.  The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. , 1993, Carcinogenesis.

[6]  R. Hoover,et al.  Risk of cancer in women receiving hormone replacement therapy , 1989, International journal of cancer.

[7]  E. Bowman,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. , 1993, Cancer research.

[8]  E. Wynder,et al.  Differences in lung cancer risk between men and women: examination of the evidence. , 1996, Journal of the National Cancer Institute.

[9]  T. Pechacek,et al.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? , 1991, Journal of the National Cancer Institute.

[10]  C. Beattie,et al.  Steroid receptors in human lung cancer. , 1985, Cancer research.

[11]  V. Ernster.  The epidemiology of lung cancer in women. , 1994, Annals of epidemiology.

[12]  H. Sugimura,et al.  The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  P. Cagle,et al.  Estrogen and progesterone receptors in bronchogenic carcinoma. , 1990, Cancer research.

[14]  J. Dosman,et al.  Female‐male differences in patients with primary lung cancer , 1987, Cancer.

[15]  D. Nebert,et al.  Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. , 1991, American journal of human genetics.

[16]  A. Lafuente,et al.  Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. , 1993, Cancer letters.

[17]  D. Phillips,et al.  Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. , 1994, Cancer research.

[18]  J. Y. Park,et al.  CYP1A1 and GSTM1 polymorphisms and oral cancer risk. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  J. Baron,et al.  The antiestrogenic effect of cigarette smoking in women , 1990 .

[20]  E. Bowman,et al.  Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. , 1999, Journal of the National Cancer Institute.

[21]  B. Mannervik,et al.  Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. , 1983, Biochemistry.

[22]  A. Rannug,et al.  Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. , 1994, Carcinogenesis.

[23]  K. Osann,et al.  Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. , 1991, Cancer research.

[24]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[25]  K. Nakachi,et al.  Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. , 1993, Cancer research.

[26]  E. Wynder,et al.  Re: Endocrine factors and adenocarcinoma of the lung in women. , 1994, Journal of the National Cancer Institute.

[27]  R. Houlston.  CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. , 2000, Pharmacogenetics.

[28]  K. Kawajiri,et al.  High Susceptibility to Lung Cancer Analyzed in Terms of Combined Genotypes of P450IA1 and Mu‐class Glutathione S‐Transferase Genes , 1992, Japanese journal of cancer research : Gann.

[29]  S. Rooney,et al.  Influence of sex hormones on lung maturation in the fetal rabbit. , 1983, Biochimica et biophysica acta.

[30]  W. Ahrens,et al.  Gender differences in lung cancer risk by smoking: a multicentre case–control study in Germany and Italy , 1999, British Journal of Cancer.

[31]  Jack A. Taylor,et al.  Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. , 1993, Journal of the National Cancer Institute.

[32]  A. Miller,et al.  Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. , 1993, American journal of epidemiology.

[33]  R. Pero,et al.  Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. , 1990, Carcinogenesis.

[34]  R. Pero,et al.  A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. , 1986, Carcinogenesis.

[35]  E. Taioli,et al.  Functional significance of different human CYP1A1 genotypes. , 1994, Carcinogenesis.

[36]  E. Taioli,et al.  A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. , 1995, Cancer research.

[37]  E. Wynder,et al.  Race and sex differences in lung cancer risk associated with cigarette smoking. , 1993, International journal of epidemiology.